2m 2m 2m 2m 2m 2m 2m
GAIN THERAPEUTIC (GANX)
NASDAQ
$1.75-$0.0010 (-0.06%)
Price as of Sep 11, 2026 7:59 PM EDT- $76.4MMarket Cap
- 5.42%1-Year Change
- BiotechnologyIndustry
GAIN THERAPEUTIC (GANX)
$1.75-$0.0010 (-0.06%)
GANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.75 | ||
Change | +$0.04 (+2.34%) | ||
Open | $1.75 | ||
High | $1.78 | ||
Low | $1.72 | ||
Previous Close | $1.71 | ||
Volume | 223,559 | ||
30-Day Average Volume | 417,192 | ||
1-Week Change | -2.78% | ||
1-Month Change | -15.05% | ||
1-Year Change | 5.42% | ||
3-Year Change | -52.19% | ||
5-Year Change | -80.62% | ||
Fundamentals | |||
Shares Outstanding | 43.6M | ||
Total Assets | $15.4M | ||
Market Cap | $76.4M | ||
Enterprise Value | $63.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$4.7M | ||
EBIT | -$4.6M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $11.5M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -16 | ||
PEG | -1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue